1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-160477
    DC-SX029 Inhibitor 98.07%
    DC-SX029 是一种口服有效的 SNX10 蛋白质-蛋白质相互作用 (PPI) 抑制剂,通过表面等离子共振 (SPR) 实验获得 KD 约为 0.935 μM。DC-SX029 阻断 SNX10-PIKfyve 相互作用,从而减少 TBK1/c-Rel 信号传导激活。DC-SX029 不影响SNX10的蛋白水平。DC-SX029 具有用于炎症性肠病 (IBD) 研究的潜力。
    DC-SX029
  • HY-N0802
    Tenuigenin

    远志皂苷元

    Inhibitor 99.24%
    Tenuigenin 是从中草药远志 (Polygala tenuifolia) 根中分离出来的主要活性成分。Tenuigenin 通过抑制 NF-κB 活化来预防金黄色葡萄球菌诱导的肺炎。
    Tenuigenin
  • HY-12286
    PI-1840 Inhibitor 98.78%
    PI-1840 是一种有效的选择性凝乳胰蛋白酶样 (CT-L) 抑制剂,其 IC50 值为 27 nM。PI-1840 抑制细胞增殖, 将细胞周期阻滞在 G2/M 期。PI-1840 诱导细胞凋亡 (apoptosis) 和自噬 (autophagy)。PI-1840 诱导蛋白酶体底物 p27、Bax 和 IκB-α 的积累。
    PI-1840
  • HY-W012732
    Isoquinoline

    异喹啉

    Inhibitor 99.66%
    Isoquinoline 是吡啶的类似物。Isoquinoline 为结构基础的生物碱,如对甲苯二异喹啉,邻苯二甲酰异喹啉和萘基异喹啉等具有抗癌活性。Berberine (属于 Isoquinoline 生物碱) 通过下调促炎/抗炎细胞因子及 Th1/Th2 细胞因子的基因表达比率在糖尿病小鼠中发挥抗炎作用。此外,一些 Isoquinoline 类化合物也具有抗抑郁、抗菌、抗疟疾和抗 HIV 活性。
    Isoquinoline
  • HY-W041489
    Chelidonic acid

    白屈菜酸

    Inhibitor 99.91%
    Chelidonic acid 是从 Chelidonium majus L. 中分到的酸类物质,为一种抗菌剂。Chelidonic acid 具有抗炎作用,可能通过抑制 NF-κBcaspase-1 来降低 IL-6 的产生。Chelidonic acid 为 glutamate decarboxylase 抑制剂,Ki 值为 1.2 μM。
    Chelidonic acid
  • HY-N0911
    Rehmannioside A

    地黄甙 A

    Inhibitor 99.96%
    Rehmannioside A 是一种可以从地黄根中分离得到的神经保护剂。Rehmannioside A 可以抑制促炎介质从小胶质细胞的释放,并在体外促进 M2 极化,从而通过抑制 NF-κB 和 MAPK 信号通路保护共培养神经元免于凋亡 (apoptosis)。Rehmannioside A 可用于脊髓损伤研究。
    Rehmannioside A
  • HY-N2381
    Menthone

    薄荷酮; 孟酮

    ≥98.0%
    Menthone,一种可以从植物和薄荷油中分离得到的具有口服活性的单萜,具有抗菌、抗肿瘤、抗氧化和抗病毒特性。Menthone 是精油的主要挥发性成分,在曼氏血吸虫感染和类风湿关节炎中具有抗炎特性。
    Menthone
  • HY-49444
    EN450 Degrader 99.28%
    EN450 是一种靶向 NF-κB 的半胱氨酸反应性共价分子胶类型的降解剂。EN450 与 E2 泛素连接酶 UBE2D 中的变构 C111 相互作用。EN450 诱导 UBE2D 和 NFKB1 之间形成三元复合物。EN450 通过 Cullin E3 连接酶和蛋白酶体依赖性机制发挥抗增殖作用。
    EN450
  • HY-78131B
    (R)-(-)-Ibuprofen

    (R)-(-)-布洛芬

    Inhibitor 99.96%
    (R)-(-)-Ibuprofen 是 Ibuprofen 的 R 型异构体,对 COX 无作用,可以抑制 NF-κB 的活化;(R)-(-)-Ibuprofen 具有抗炎作用,可用于缓解疼痛的研究。
    (R)-(-)-Ibuprofen
  • HY-125911
    Gossypin Inhibitor 98.04%
    Gossypin 是从 Hibiscus vitifolius 中分离得到的一种黄酮,具有抗氧化、抗炎、抗癌、抗衰老、抗糖尿病和保护肝脏的活性。Gossypin 抑制 NF-κBNF-κB 的调节基因表达。在小鼠原代骨髓细胞和 RAW264.7 细胞中,Gossypin 也可抑制 RANKL 诱导的破骨细胞形成。
    Gossypin
  • HY-112569
    MAT2A inhibitor 2 Inhibitor 99.71%
    MAT2A inhibitor 2 是一种具有口服活性的甲硫氨酸腺苷转移酶 2A (MAT2A) 的抑制剂。MAT2A inhibitor 2 可用于骨质疏松症的研究。
    MAT2A inhibitor 2
  • HY-107352
    Fosfenopril

    福辛普利拉EP杂质A)

    Inhibitor 99.89%
    Fosfenopril (Fosinoprilat) 是一种有效的血管紧张素转换酶 (ACE) 抑制剂。Fosfenopril 通过抑制单核细胞中 TLR4/NF-κB 信号通路缓解脂多糖 (LPS) 诱导的炎症反应。
    Fosfenopril
  • HY-W001174
    2,5-Dihydroxyacetophenone

    2,5-二羟基苯乙酮

    Inhibitor 99.75%
    2,5-Dihydroxyacetophenone 是从熟地黄中分离出的,可通过阻断 ERK1/2NF-κB 信号通路来抑制活化巨噬细胞中炎症介质的产生。
    2,5-Dihydroxyacetophenone
  • HY-121632
    Quinoclamine

    灭藻醌

    Inhibitor 99.55%
    Quinoclamine 是一种萘醌衍生物,是一种 NF-κB 抑制剂。Quinoclamine 具有抗肿瘤活性。
    Quinoclamine
  • HY-10072
    SPC 839 Inhibitor 99.86%
    SPC 839 (compound 10) 是一种具有口服活性的 AP-1NF-kB 介导的转录激活抑制剂,其 IC50 值为 0.008 μM。
    SPC 839
  • HY-N0758
    Barlerin

    8-O-乙酰山栀苷甲酯

    99.82%
    Barlerin (8-O-Acetyl shanzhiside methyl ester) 是从中国西藏民间药用植物中分离出的环孢菌素葡萄糖苷。Barlerin (8-O-Acetyl shanzhiside methyl ester) 可以抑制 NF-κB 活性。
    Barlerin
  • HY-N4314
    Scutellarein tetramethyl ether

    黄芩四甲基醚

    Inhibitor 99.93%
    Scutellarein tetramethyl ether (4',5,6,7-Tetramethoxyflavone) 是可以从 Eupatorium odoratum 中得到的生物活性成分。Scutellarein tetramethyl ether 具有抗炎、抗菌、增强凝血和抗肿瘤的活性。Scutellarein tetramethyl ether 通过调节 NF-κB 通路发挥抗炎作用,并通过抑制外排泵来调节细菌耐药性。此外,Scutellarein tetramethyl ether 通过内源性凝血途径加速凝血时间。研究表明,Scutellarein tetramethyl ether 能有效抑制肝癌细胞系 HepG2 的生长 (IC50= 20.08 μg/mL)。
    Scutellarein tetramethyl ether
  • HY-N0277
    Aconine

    乌头原碱

    Inhibitor 99.78%
    Aconine 抑制核因子 κB 受体活化剂配体诱导的 NF-κB 激活。
    Aconine
  • HY-N4110
    Friedelin

    软木三萜酮

    Inhibitor ≥99.0%
    Friedelin 源自 Maytenus ilicifolia(Mart) 的叶子。 Friedelin 是一种具有口服活性的 CYP3A4 非竞争性抑制剂,IC50Ki 值分别为 10.79 μM 和 6.16 μM。 Friedelin 还是 CYP2E1 的竞争性抑制剂,IC50Ki 值分别为 22.54 μM 和 18.02 μM。Friedelin 可用于炎症、神经疾病以及代谢疾病领域的研究。
    Friedelin
  • HY-N7128
    Flavanone

    黄烷酮

    Inhibitor 99.84%
    Flavanone 是一种天然的黄酮类化合物。Flavanone 对人类雌激素合成酶芳香化酶 (aromatase) 具有抑制作用。Flavanone 是 ERK/p38/NF-κB 信号通路的抑制剂。Flavanone 具有口服活性和抗肿瘤活性。
    Flavanone
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.